Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aethlon Medical (AEMD)
Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,423
  • Shares Outstanding, K 22,969
  • Annual Sales, $ 290 K
  • Annual Income, $ -10,420 K
  • 60-Month Beta 1.25
  • Price/Sales 30.47
  • Price/Cash Flow N/A
  • Price/Book 0.52
Trade AEMD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.74
  • Most Recent Earnings -0.12 on 02/13/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 826.00% ( +39.67%)
  • Historical Volatility 57.43%
  • IV Percentile 91%
  • IV Rank 60.61%
  • IV High 1,323.47% on 11/18/22
  • IV Low 60.65% on 09/22/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,018
  • Open Int (30-Day) 1,226

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate 0.91
  • Number of Estimates 2
  • High Estimate 1.98
  • Low Estimate -0.16
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +464.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3518 +9.49%
on 03/20/23
0.5790 -33.47%
on 02/22/23
-0.1366 (-26.18%)
since 02/21/23
3-Month
0.2250 +71.20%
on 12/22/22
0.8700 -55.72%
on 01/30/23
+0.0942 (+32.37%)
since 12/21/22
52-Week
0.2250 +71.20%
on 12/22/22
2.4600 -84.34%
on 08/03/22
-1.0848 (-73.80%)
since 03/21/22

Most Recent Stories

More News
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...

AEMD : 0.3852 (+5.04%)
Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023

/PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...

AEMD : 0.3852 (+5.04%)
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease,...

AEMD : 0.3852 (+5.04%)
Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today...

AEMD : 0.3852 (+5.04%)
Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...

AEMD : 0.3852 (+5.04%)
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...

AEMD : 0.3852 (+5.04%)
Aethlon Medical to Present at Two Investor Conferences in September

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and...

AEMD : 0.3852 (+5.04%)
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...

AEMD : 0.3852 (+5.04%)
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...

AEMD : 0.3852 (+5.04%)
Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...

AEMD : 0.3852 (+5.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development...

See More

Key Turning Points

3rd Resistance Point 0.4271
2nd Resistance Point 0.4090
1st Resistance Point 0.3879
Last Price 0.3852
1st Support Level 0.3487
2nd Support Level 0.3306
3rd Support Level 0.3095

See More

52-Week High 2.4600
Fibonacci 61.8% 1.6062
Fibonacci 50% 1.3425
Fibonacci 38.2% 1.0788
Last Price 0.3852
52-Week Low 0.2250

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar